Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Taiwan
58%
Confidence Interval
33%
Hepatitis C Virus
25%
Hazard Ratio
24%
Hepatocellular Carcinoma Patients
20%
Mesenchymal Stem Cells
20%
Chronic Hepatitis C
20%
Hepatitis C
19%
Cirrhosis
19%
Overall Survival
19%
Migraine
19%
Endothelial Progenitor Cells
18%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
17%
Risk Factors
16%
Reversible Cerebral Vasoconstriction Syndrome
15%
Head-and-neck Cancer
14%
Transarterial Chemoembolization
14%
Hepatitis B Virus
14%
Human Mesenchymal Stem Cells (hMSCs)
13%
Clinical Outcomes
13%
Human Immunodeficiency Virus Type 1 (HIV-1)
13%
Taiwanese
13%
National Cohort Study
13%
Chronic Hepatitis B
13%
Prognostic Factors
13%
Hepatitis B Surface Antigen (HBsAg)
13%
Multivariate Analysis
12%
Human Endothelial Progenitor Cells
12%
Epithelial-mesenchymal Transition
11%
Ruptured Abdominal Aortic Aneurysm (rAAA)
11%
Odds Ratio
10%
Radiofrequency Ablation
10%
Albumin-bilirubin Grade
10%
Chronic Kidney Disease
10%
Chemotherapy
10%
High Risk
10%
Chronic Migraine
10%
Tumor
9%
Alpha-fetoprotein
9%
Taipei
9%
Direct-acting Antivirals
9%
Stem Cells
9%
Sustained Virological Response
9%
Surgical Resection
9%
Headache
9%
Hepatitis C Virus Infection
9%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
8%
Cancer Cells
8%
Chronic Hepatitis B Patients
8%
Cardiovascular Events
8%
Liver
8%
Hepatitis B e Antigen (HBeAg)
8%
Mesenchymal Stromal Cells
7%
Immune Checkpoint Inhibitors
7%
Gag-Pol
7%
COVID-19
7%
Hepatitis B
7%
Macrophages
7%
Angiogenesis
7%
Metastasis
7%
Barcelona Clinic Liver Cancer
7%
Hepatocellular Carcinoma Risk
7%
Osteogenic Differentiation
7%
Treatment Outcome
7%
Advanced Hepatocellular Carcinoma
7%
Acute Kidney Injury
7%
Arteriovenous Fistula
7%
Cell Function
7%
Coronary Artery Bypass Grafting
7%
Acute Myocardial Infarction
6%
Type 1 Diabetes Mellitus (T1DM)
6%
Inflammation
6%
All-cause Mortality
6%
Liver Cirrhosis
6%
Virus
6%
Ischemic Stroke
6%
Major Adverse Cardiovascular Events
6%
Sofosbuvir
6%
Antiretroviral Therapy
6%
Progression-free Survival
6%
Propensity Score Analysis
6%
Cirrhotic Patients
6%
Neovascularization
6%
Virus-like
6%
Oxidative Stress
6%
Cox Proportional Hazards Model
6%
General Hospital
6%
Recurrent Metastatic
6%
Percutaneous Coronary Intervention
6%
Computed Tomography
5%
Hemodialysis Patients
5%
Unresectable Hepatocellular Carcinoma
5%
MELD Score
5%
Meta-analysis
5%
Coronary Artery Disease
5%
Cetuximab
5%
Overexpression
5%
Comorbidity
5%
Estimated Glomerular Filtration Rate
5%
Medicine and Dentistry
Hepatocellular Carcinoma
96%
Neoplasm
24%
Liver Cirrhosis
19%
Hazard Ratio
18%
Hepatitis B Virus
18%
Overall Survival
18%
Hepatitis C Virus
18%
Surgery
16%
Mesenchymal Stem Cell
16%
Diseases
15%
Cardiovascular System
15%
Transcatheter Arterial Chemoembolization
15%
Endothelial Progenitor Cell
15%
Chronic Hepatitis C
14%
Coronary Artery Disease
14%
Migraine
13%
Cohort Analysis
12%
Chronic Hepatitis B
12%
Bilirubin
12%
Hepatitis C
11%
Malignant Neoplasm
11%
Prevalence
11%
Infection
11%
Odds Ratio
10%
Diabetes Mellitus
10%
Chronic Kidney Disease
10%
Head and Neck Squamous Cell Carcinoma
10%
Headache
10%
Proportional Hazards Model
9%
Prognostic Factor
9%
Liver Cancer
9%
Hemodialysis
9%
Multivariate Analysis
9%
Radiofrequency Ablation
8%
Recurrent Disease
8%
Aortic Dissection
8%
Acute Kidney Injury
8%
Metastatic Carcinoma
7%
Hepatitis B
7%
In Vitro
7%
Cardiovascular Disease
7%
Arteriovenous Fistula
7%
Reversible Cerebral Vasoconstriction Syndrome
7%
Biological Marker
7%
Liver Disease
7%
Abdominal Aortic Aneurysm
7%
Cancer Staging
7%
Platelet
7%
Fibrosis
7%
Antiviral Therapy
6%
Endovascular Aneurysm Repair
6%
Breast Cancer
6%
Antiviral Drug
6%
Cancer
6%
Head and Neck Cancer
6%
Computer Assisted Tomography
6%
Kidney Function
6%
Survival Rate
6%
Coronary Artery Bypass Graft
6%
Angiogenesis
6%
Stem Cell
6%
Immune Checkpoint Inhibitor
5%
End Stage Renal Disease
5%
Percutaneous Coronary Intervention
5%
Squamous Cell Carcinoma
5%
Stent-Graft
5%
Adverse Event
5%
Apoplexy
5%
Immunotherapy
5%
Immunity
5%
Progression Free Survival
5%
Retrospective Study
5%
Fabry Disease
5%
Cancer Cell
5%
Mouth Squamous Cell Carcinoma
5%